Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats

The contribution of tyrosine kinase activity to vasoreactivity in normotensive Wistar–Kyoto (WKY) and spontaneously hypertensive (SHR) rats was investigated on isolated aortic preparations by the use of two tyrosine kinase inhibitors: methyl-2,5-dihydroxycinnamate (30 μM) and genistein (30 μM). The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 1999-06, Vol.374 (1), p.49-58
Hauptverfasser: Zerrouk, Abdellatif, Auguet, Michel, Dabiré, Hubert, Brisac, Anne-Marie, Safar, Michel, Chabrier, Pierre-Etienne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 58
container_issue 1
container_start_page 49
container_title European journal of pharmacology
container_volume 374
creator Zerrouk, Abdellatif
Auguet, Michel
Dabiré, Hubert
Brisac, Anne-Marie
Safar, Michel
Chabrier, Pierre-Etienne
description The contribution of tyrosine kinase activity to vasoreactivity in normotensive Wistar–Kyoto (WKY) and spontaneously hypertensive (SHR) rats was investigated on isolated aortic preparations by the use of two tyrosine kinase inhibitors: methyl-2,5-dihydroxycinnamate (30 μM) and genistein (30 μM). The pretreatment of endothelium denuded aorta with methyl-2,5-dihydroxycinnamate reduced the sensitivity of the rings to noradrenaline to a larger extent in SHR than in WKY. The relaxing effects evoked by methyl-2,5-dihydroxycinnamate and genistein on the sustained contraction induced by endothelin-1 were also more pronounced in SHR denuded rings. Furthermore, in presence of methyl-2,5-dihydroxycinnamate, the endothelium-independent contractile responses to equipotent doses of cyclopiazonic acid were more depressed in SHR than in WKY. In WKY and SHR endothelium-intact aortas contracted with either phenylephrine or endothelin-1, carbachol and cyclopiazonic acid evoked endothelium derived relaxing factor (EDRF)/nitric oxide (NO)-dependent relaxations which were reduced by pretreatment of the rings with methyl-2,5-dihydroxycinnamate or genistein. These inhibitory effects were larger in WKY rings and more important on the cyclopiazonic acid response. In addition, sodium orthovanadate (30 μM) potentiated the noradrenaline-mediated contractions of endothelium-denuded SHR rings and reduced the cyclopiazonic acid-induced relaxation of endothelium-intact WKY rings. The present study suggests a regulatory role for tyrosine kinase in the smooth muscle contraction and the endothelium-dependent relaxation in WKY and SHR aortas and demonstrates the existence of a different relationship in the effect of tyrosine kinase inhibitors on vasoreactivity between SHR and WKY. We propose that an increase in the tyrosine kinase activity in SHR could lead to an enhanced reactivity of Ca 2+-linked contractile mechanisms. In addition, our results suggest a link between the loss of tyrosine kinase activity and the altered endothelium-dependent relaxation associated with hypertension.
doi_str_mv 10.1016/S0014-2999(99)00304-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69911936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299999003040</els_id><sourcerecordid>69911936</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-2723c694abde892c1a0820cfc808577aa20b443e0bbd4be48695d3a587d9e9c43</originalsourceid><addsrcrecordid>eNqFkV1vFCEUhonR2LX2J2jmwhh7MfbAMB9cGVPtR9LEi9prcoY5k0VnYQW2ce_94WVn19Y7ExIO8LwH8sDYGw4fOfDm7BaAy1IopT4odQpQgSzhGVvwrlUltFw8Z4tH5Ii9ivEHANRK1C_ZEQcpRCNhwf58seNIgVyyOBWUa5Ni4ccibYOP1lHx0zqMVFi3tL1NPuRTVxjvUkCTbK7RDUWgCX_jvNxll1SgDwnnTs6HlU_kor2nGV5u1xT-bgRM8TV7MeIU6eQwH7O7i6_fz6_Km2-X1-efb0pTKUilaEVlGiWxH6hTwnCEToAZTQdd3baIAnopK4K-H2RPsmtUPVRYd-2gSBlZHbP3-77r4H9tKCa9stHQNKEjv4m6UYpzVTUZrPegyRJioFGvg11h2GoOeqdfz_r1zq3OY9avIefeHi7Y9Csa_kntfWfg3QHAaHAaAzpj4xPXSWjVDvu0xyjbuLcUdDSWnKHBhvxBevD2Py95AGIZpIc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69911936</pqid></control><display><type>article</type><title>Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zerrouk, Abdellatif ; Auguet, Michel ; Dabiré, Hubert ; Brisac, Anne-Marie ; Safar, Michel ; Chabrier, Pierre-Etienne</creator><creatorcontrib>Zerrouk, Abdellatif ; Auguet, Michel ; Dabiré, Hubert ; Brisac, Anne-Marie ; Safar, Michel ; Chabrier, Pierre-Etienne</creatorcontrib><description>The contribution of tyrosine kinase activity to vasoreactivity in normotensive Wistar–Kyoto (WKY) and spontaneously hypertensive (SHR) rats was investigated on isolated aortic preparations by the use of two tyrosine kinase inhibitors: methyl-2,5-dihydroxycinnamate (30 μM) and genistein (30 μM). The pretreatment of endothelium denuded aorta with methyl-2,5-dihydroxycinnamate reduced the sensitivity of the rings to noradrenaline to a larger extent in SHR than in WKY. The relaxing effects evoked by methyl-2,5-dihydroxycinnamate and genistein on the sustained contraction induced by endothelin-1 were also more pronounced in SHR denuded rings. Furthermore, in presence of methyl-2,5-dihydroxycinnamate, the endothelium-independent contractile responses to equipotent doses of cyclopiazonic acid were more depressed in SHR than in WKY. In WKY and SHR endothelium-intact aortas contracted with either phenylephrine or endothelin-1, carbachol and cyclopiazonic acid evoked endothelium derived relaxing factor (EDRF)/nitric oxide (NO)-dependent relaxations which were reduced by pretreatment of the rings with methyl-2,5-dihydroxycinnamate or genistein. These inhibitory effects were larger in WKY rings and more important on the cyclopiazonic acid response. In addition, sodium orthovanadate (30 μM) potentiated the noradrenaline-mediated contractions of endothelium-denuded SHR rings and reduced the cyclopiazonic acid-induced relaxation of endothelium-intact WKY rings. The present study suggests a regulatory role for tyrosine kinase in the smooth muscle contraction and the endothelium-dependent relaxation in WKY and SHR aortas and demonstrates the existence of a different relationship in the effect of tyrosine kinase inhibitors on vasoreactivity between SHR and WKY. We propose that an increase in the tyrosine kinase activity in SHR could lead to an enhanced reactivity of Ca 2+-linked contractile mechanisms. In addition, our results suggest a link between the loss of tyrosine kinase activity and the altered endothelium-dependent relaxation associated with hypertension.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(99)00304-0</identifier><identifier>PMID: 10422640</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Aorta - drug effects ; Aorta - physiology ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Calcium - metabolism ; Carbachol - pharmacology ; Cardiology. Vascular system ; Cyclopiazonic acid ; Endothelin-1 ; Endothelin-1 - pharmacology ; Endothelium ; Experimental diseases ; Hypertension - physiopathology ; Indoles - pharmacology ; Male ; Medical sciences ; Noradrenaline ; Protein Tyrosine Phosphatases - antagonists &amp; inhibitors ; Protein Tyrosine Phosphatases - physiology ; Protein-Tyrosine Kinases - antagonists &amp; inhibitors ; Protein-Tyrosine Kinases - physiology ; Rats ; Rats, Inbred SHR ; Rats, Inbred WKY ; Spontaneously hypertensive rat (SHR) ; Tyrosine kinase ; Vasoconstriction - drug effects ; Vasodilation - drug effects</subject><ispartof>European journal of pharmacology, 1999-06, Vol.374 (1), p.49-58</ispartof><rights>1999 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-2723c694abde892c1a0820cfc808577aa20b443e0bbd4be48695d3a587d9e9c43</citedby><cites>FETCH-LOGICAL-c390t-2723c694abde892c1a0820cfc808577aa20b443e0bbd4be48695d3a587d9e9c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014299999003040$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1840790$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10422640$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zerrouk, Abdellatif</creatorcontrib><creatorcontrib>Auguet, Michel</creatorcontrib><creatorcontrib>Dabiré, Hubert</creatorcontrib><creatorcontrib>Brisac, Anne-Marie</creatorcontrib><creatorcontrib>Safar, Michel</creatorcontrib><creatorcontrib>Chabrier, Pierre-Etienne</creatorcontrib><title>Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The contribution of tyrosine kinase activity to vasoreactivity in normotensive Wistar–Kyoto (WKY) and spontaneously hypertensive (SHR) rats was investigated on isolated aortic preparations by the use of two tyrosine kinase inhibitors: methyl-2,5-dihydroxycinnamate (30 μM) and genistein (30 μM). The pretreatment of endothelium denuded aorta with methyl-2,5-dihydroxycinnamate reduced the sensitivity of the rings to noradrenaline to a larger extent in SHR than in WKY. The relaxing effects evoked by methyl-2,5-dihydroxycinnamate and genistein on the sustained contraction induced by endothelin-1 were also more pronounced in SHR denuded rings. Furthermore, in presence of methyl-2,5-dihydroxycinnamate, the endothelium-independent contractile responses to equipotent doses of cyclopiazonic acid were more depressed in SHR than in WKY. In WKY and SHR endothelium-intact aortas contracted with either phenylephrine or endothelin-1, carbachol and cyclopiazonic acid evoked endothelium derived relaxing factor (EDRF)/nitric oxide (NO)-dependent relaxations which were reduced by pretreatment of the rings with methyl-2,5-dihydroxycinnamate or genistein. These inhibitory effects were larger in WKY rings and more important on the cyclopiazonic acid response. In addition, sodium orthovanadate (30 μM) potentiated the noradrenaline-mediated contractions of endothelium-denuded SHR rings and reduced the cyclopiazonic acid-induced relaxation of endothelium-intact WKY rings. The present study suggests a regulatory role for tyrosine kinase in the smooth muscle contraction and the endothelium-dependent relaxation in WKY and SHR aortas and demonstrates the existence of a different relationship in the effect of tyrosine kinase inhibitors on vasoreactivity between SHR and WKY. We propose that an increase in the tyrosine kinase activity in SHR could lead to an enhanced reactivity of Ca 2+-linked contractile mechanisms. In addition, our results suggest a link between the loss of tyrosine kinase activity and the altered endothelium-dependent relaxation associated with hypertension.</description><subject>Animals</subject><subject>Aorta - drug effects</subject><subject>Aorta - physiology</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Calcium - metabolism</subject><subject>Carbachol - pharmacology</subject><subject>Cardiology. Vascular system</subject><subject>Cyclopiazonic acid</subject><subject>Endothelin-1</subject><subject>Endothelin-1 - pharmacology</subject><subject>Endothelium</subject><subject>Experimental diseases</subject><subject>Hypertension - physiopathology</subject><subject>Indoles - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Noradrenaline</subject><subject>Protein Tyrosine Phosphatases - antagonists &amp; inhibitors</subject><subject>Protein Tyrosine Phosphatases - physiology</subject><subject>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</subject><subject>Protein-Tyrosine Kinases - physiology</subject><subject>Rats</subject><subject>Rats, Inbred SHR</subject><subject>Rats, Inbred WKY</subject><subject>Spontaneously hypertensive rat (SHR)</subject><subject>Tyrosine kinase</subject><subject>Vasoconstriction - drug effects</subject><subject>Vasodilation - drug effects</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1vFCEUhonR2LX2J2jmwhh7MfbAMB9cGVPtR9LEi9prcoY5k0VnYQW2ce_94WVn19Y7ExIO8LwH8sDYGw4fOfDm7BaAy1IopT4odQpQgSzhGVvwrlUltFw8Z4tH5Ii9ivEHANRK1C_ZEQcpRCNhwf58seNIgVyyOBWUa5Ni4ccibYOP1lHx0zqMVFi3tL1NPuRTVxjvUkCTbK7RDUWgCX_jvNxll1SgDwnnTs6HlU_kor2nGV5u1xT-bgRM8TV7MeIU6eQwH7O7i6_fz6_Km2-X1-efb0pTKUilaEVlGiWxH6hTwnCEToAZTQdd3baIAnopK4K-H2RPsmtUPVRYd-2gSBlZHbP3-77r4H9tKCa9stHQNKEjv4m6UYpzVTUZrPegyRJioFGvg11h2GoOeqdfz_r1zq3OY9avIefeHi7Y9Csa_kntfWfg3QHAaHAaAzpj4xPXSWjVDvu0xyjbuLcUdDSWnKHBhvxBevD2Py95AGIZpIc</recordid><startdate>19990611</startdate><enddate>19990611</enddate><creator>Zerrouk, Abdellatif</creator><creator>Auguet, Michel</creator><creator>Dabiré, Hubert</creator><creator>Brisac, Anne-Marie</creator><creator>Safar, Michel</creator><creator>Chabrier, Pierre-Etienne</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990611</creationdate><title>Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats</title><author>Zerrouk, Abdellatif ; Auguet, Michel ; Dabiré, Hubert ; Brisac, Anne-Marie ; Safar, Michel ; Chabrier, Pierre-Etienne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-2723c694abde892c1a0820cfc808577aa20b443e0bbd4be48695d3a587d9e9c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Aorta - drug effects</topic><topic>Aorta - physiology</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Calcium - metabolism</topic><topic>Carbachol - pharmacology</topic><topic>Cardiology. Vascular system</topic><topic>Cyclopiazonic acid</topic><topic>Endothelin-1</topic><topic>Endothelin-1 - pharmacology</topic><topic>Endothelium</topic><topic>Experimental diseases</topic><topic>Hypertension - physiopathology</topic><topic>Indoles - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Noradrenaline</topic><topic>Protein Tyrosine Phosphatases - antagonists &amp; inhibitors</topic><topic>Protein Tyrosine Phosphatases - physiology</topic><topic>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</topic><topic>Protein-Tyrosine Kinases - physiology</topic><topic>Rats</topic><topic>Rats, Inbred SHR</topic><topic>Rats, Inbred WKY</topic><topic>Spontaneously hypertensive rat (SHR)</topic><topic>Tyrosine kinase</topic><topic>Vasoconstriction - drug effects</topic><topic>Vasodilation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zerrouk, Abdellatif</creatorcontrib><creatorcontrib>Auguet, Michel</creatorcontrib><creatorcontrib>Dabiré, Hubert</creatorcontrib><creatorcontrib>Brisac, Anne-Marie</creatorcontrib><creatorcontrib>Safar, Michel</creatorcontrib><creatorcontrib>Chabrier, Pierre-Etienne</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zerrouk, Abdellatif</au><au>Auguet, Michel</au><au>Dabiré, Hubert</au><au>Brisac, Anne-Marie</au><au>Safar, Michel</au><au>Chabrier, Pierre-Etienne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1999-06-11</date><risdate>1999</risdate><volume>374</volume><issue>1</issue><spage>49</spage><epage>58</epage><pages>49-58</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>The contribution of tyrosine kinase activity to vasoreactivity in normotensive Wistar–Kyoto (WKY) and spontaneously hypertensive (SHR) rats was investigated on isolated aortic preparations by the use of two tyrosine kinase inhibitors: methyl-2,5-dihydroxycinnamate (30 μM) and genistein (30 μM). The pretreatment of endothelium denuded aorta with methyl-2,5-dihydroxycinnamate reduced the sensitivity of the rings to noradrenaline to a larger extent in SHR than in WKY. The relaxing effects evoked by methyl-2,5-dihydroxycinnamate and genistein on the sustained contraction induced by endothelin-1 were also more pronounced in SHR denuded rings. Furthermore, in presence of methyl-2,5-dihydroxycinnamate, the endothelium-independent contractile responses to equipotent doses of cyclopiazonic acid were more depressed in SHR than in WKY. In WKY and SHR endothelium-intact aortas contracted with either phenylephrine or endothelin-1, carbachol and cyclopiazonic acid evoked endothelium derived relaxing factor (EDRF)/nitric oxide (NO)-dependent relaxations which were reduced by pretreatment of the rings with methyl-2,5-dihydroxycinnamate or genistein. These inhibitory effects were larger in WKY rings and more important on the cyclopiazonic acid response. In addition, sodium orthovanadate (30 μM) potentiated the noradrenaline-mediated contractions of endothelium-denuded SHR rings and reduced the cyclopiazonic acid-induced relaxation of endothelium-intact WKY rings. The present study suggests a regulatory role for tyrosine kinase in the smooth muscle contraction and the endothelium-dependent relaxation in WKY and SHR aortas and demonstrates the existence of a different relationship in the effect of tyrosine kinase inhibitors on vasoreactivity between SHR and WKY. We propose that an increase in the tyrosine kinase activity in SHR could lead to an enhanced reactivity of Ca 2+-linked contractile mechanisms. In addition, our results suggest a link between the loss of tyrosine kinase activity and the altered endothelium-dependent relaxation associated with hypertension.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>10422640</pmid><doi>10.1016/S0014-2999(99)00304-0</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1999-06, Vol.374 (1), p.49-58
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_69911936
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Aorta - drug effects
Aorta - physiology
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Calcium - metabolism
Carbachol - pharmacology
Cardiology. Vascular system
Cyclopiazonic acid
Endothelin-1
Endothelin-1 - pharmacology
Endothelium
Experimental diseases
Hypertension - physiopathology
Indoles - pharmacology
Male
Medical sciences
Noradrenaline
Protein Tyrosine Phosphatases - antagonists & inhibitors
Protein Tyrosine Phosphatases - physiology
Protein-Tyrosine Kinases - antagonists & inhibitors
Protein-Tyrosine Kinases - physiology
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Spontaneously hypertensive rat (SHR)
Tyrosine kinase
Vasoconstriction - drug effects
Vasodilation - drug effects
title Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T03%3A45%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20effects%20of%20tyrosine%20kinase%20inhibitors%20on%20contraction%20and%20relaxation%20of%20the%20aortas%20of%20normotensive%20and%20hypertensive%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Zerrouk,%20Abdellatif&rft.date=1999-06-11&rft.volume=374&rft.issue=1&rft.spage=49&rft.epage=58&rft.pages=49-58&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(99)00304-0&rft_dat=%3Cproquest_cross%3E69911936%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69911936&rft_id=info:pmid/10422640&rft_els_id=S0014299999003040&rfr_iscdi=true